Are atenolol, atorvastatin, glucosamine, calcium, and trandolapril (angiotensin-converting enzyme inhibitor) associated with pancreatitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Atorvastatin has a known association with pancreatitis, though it is rare, and trandolapril has also been linked to rare cases of pancreatitis. When considering the medications listed, it's crucial to weigh the risk of pancreatitis against the benefits of treatment.

  • Atenolol, a beta-blocker, has not been significantly linked to pancreatitis in clinical literature 1.
  • Glucosamine, a supplement for joint health, and calcium supplements also lack a significant association with pancreatitis 1.
  • Atorvastatin, a statin medication, has been reported to cause acute pancreatitis in some patients, typically within the first few months of therapy, with a mechanism that may involve direct toxic effects on pancreatic tissue or immune-mediated reactions 1.
  • Trandolapril, an ACE inhibitor, has been associated with rare cases of pancreatitis, emphasizing the need for vigilance in patients taking this medication 1. Key considerations for managing patients on these medications include monitoring for symptoms of pancreatitis, such as severe abdominal pain radiating to the back, nausea, vomiting, or elevated pancreatic enzymes, and potentially discontinuing the medication after consultation with a healthcare provider if pancreatitis is suspected. The treatment goal for patients with hypertriglyceridemia, which may involve the use of statins like atorvastatin, should balance the risk of pancreatitis with the benefits of reducing cardiovascular risk, as outlined in guidelines such as those from the Endocrine Society 1.

From the FDA Drug Label

Gastrointestinal Disorders: pancreatitis The medication atorvastatin has an association with pancreatitis, as it is listed under the postmarketing experience section of the drug label as a reported adverse reaction 2.

  • Atenolol, glucosamine, calcium, and trandolapril are not mentioned in the provided drug label as having an association with pancreatitis. No conclusion can be drawn about these medications regarding pancreatitis based on the provided information.

From the Research

Association with Pancreatitis

The medications listed are atenolol, atorvastatin, glucosamine, calcium, and trandolapril. Among these, atorvastatin has been associated with pancreatitis in several studies:

  • Atorvastatin has been reported to cause acute pancreatitis in a few cases, with the exact mechanism unknown 3, 4, 5.
  • A case-control study in Taiwan found that current use of atorvastatin was associated with an increased risk of acute pancreatitis, with an odds ratio of 1.67 6.
  • A systematic review of observational studies and spontaneous case reports found that statins, including atorvastatin, were associated with an increased risk of acute pancreatitis, with an odds ratio of 1.41 7.

Other Medications

There is no evidence in the provided studies to suggest an association between pancreatitis and the following medications:

  • Atenolol
  • Glucosamine
  • Calcium
  • Trandolapril

Key Findings

  • Atorvastatin has been associated with an increased risk of acute pancreatitis in several studies 3, 4, 5, 6, 7.
  • The exact mechanism of atorvastatin-induced pancreatitis is unknown, but it may be a class effect of HMG CoA reductase inhibitors 3, 4, 7.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.